ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225.7 CNY | +2.48% |
|
-0.15% | -6.74% |
| Sales 2024 * | 11.6B 1.6B 2.19B | Sales 2025 * | 13.26B 1.83B 2.5B | Capitalization | 136B 18.79B 25.69B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.35B 462M 632M | Net income 2025 * | 3.97B 548M 749M | EV / Sales 2024 * | 11.5 x |
| Net cash position 2024 * | 2.41B 333M 455M | Net cash position 2025 * | 3.68B 508M 695M | EV / Sales 2025 * | 9.99 x |
| P/E ratio 2024 * |
40.6
x | P/E ratio 2025 * |
34.3
x | Employees | 2,789 |
| Yield 2024 * |
1.13% | Yield 2025 * |
1.08% | Free-Float | 38.58% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.48% | ||
| 1 week | -0.15% | ||
| Current month | -1.24% | ||
| 1 month | -2.80% | ||
| 3 months | -1.02% | ||
| 6 months | -8.63% | ||
| Current year | -6.74% |
1 week
219.00
234.50
1 month
216.48237.20
Current year
180.69242.98
1 year
180.69321.00
3 years
180.69491.88
5 years
90.96491.88
10 years
19.63491.88
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Ming Huang
CEO | Chief Executive Officer | 58 | 16-04-17 |
Hai Peng Yang
BRD | Director/Board Member | 58 | 10-06-30 |
Ya Long Huang
BRD | Director/Board Member | 59 | 86-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shou Ying Du
BRD | Director/Board Member | 64 | 22-01-19 |
Jin Ming Huang
CEO | Chief Executive Officer | 58 | 16-04-17 |
Zhi Peng Fan
BRD | Director/Board Member | 48 | 18-03-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.00% | 2 M€ | -16.59% | - | |
| 2.49% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 225.7 | +2.48% | 2,728,491 |
| 24-04-25 | 220.2 | -2.08% | 2,566,988 |
| 24-04-24 | 224.9 | -1.94% | 1,801,985 |
| 24-04-23 | 229.4 | +0.86% | 1,820,343 |
| 24-04-22 | 227.4 | +0.60% | 2,366,916 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is specialized in developing and marketing traditional Chinese medicine products. The company offers medicines and health products, cosmetic products, dietary compounds, etc.
Sector
Pharmaceuticals
Calendar
2024-05-19
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
225.7
CNY
Average target price
285.6
CNY
Spread / Average Target
+26.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.74% | 18.79B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 600436 Stock
